Drug intelligence / Profile preview

CS20AT04

Development stage
Approved
Lead developer
Corestemchemon
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

CS20AT04 is an allogeneic cell therapy consisting of HLA-haplo matched bone marrow-derived mesenchymal stem cells (MSCs). Developed by Corestemchemon (formerly Corestem), it is designed to treat autoimmune conditions, specifically systemic lupus erythematosus (SLE) and its complications, such as lupus nephritis and lupus cytopenia. The therapy leverages the immunomodulatory and anti-inflammatory properties of MSCs to regulate the aberrant immune response characteristic of lupus. Clinical evaluation has included Phase 1 safety and tolerability studies in lupus nephritis patients, where it was found to be well-tolerated at doses up to 3.0 x 10^6 cells/kg, as well as investigator-led Phase 2a studies exploring its efficacy in both lupus nephritis and lupus cytopenia.

Other names
HLA-haplo Matched Allogenic Bone Marrow-Derived Stem CellsAllogenic bone marrow-derived mesenchymal stem cells

Beyond the preview

Go deeper on CS20AT04.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CS20AT04.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call